Hematopoietic lineage commitment: Role of transcription factors

STEM CELLS

Volumn 13, Issue 3, 1995, Pages 223-241

  Kehrl, John H ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Differentiation; Hematopoiesis; Lineage; Lymphopoiesis; Myelopoiesis; Transcription

Indexed keywords

CD34 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; COMPLEMENTARY DNA; HOMEODOMAIN PROTEIN; LEUCINE ZIPPER PROTEIN; TRANSCRIPTION FACTOR; ZINC FINGER PROTEIN;

B LYMPHOCYTE; CELL SPECIFICITY; ERYTHROPOIESIS; GENE EXPRESSION REGULATION; HEMATOPOIETIC STEM CELL; HUMAN; LYMPHOPOIESIS; MAST CELL; MEGAKARYOCYTE; MEGAKARYOPOIESIS; MYELOPOIESIS; NONHUMAN; PROMOTER REGION; PROTEIN DNA BINDING; REVIEW; T LYMPHOCYTE; T LYMPHOCYTE RECEPTOR GENE; TRANSCRIPTION REGULATION;

ANIMAL; BASE SEQUENCE; ERYTHROID PROGENITOR CELLS; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; HUMAN; LYMPHOCYTES; MAST CELLS; MEGAKARYOCYTES; MOLECULAR SEQUENCE DATA; MONOCYTES; TRANSCRIPTION FACTORS;

EID: 0029001961     PISSN: 10665099     EISSN: 15494918     Source Type: Journal    
DOI: 10.1002/stem.5530130304     Document Type: Article

References (169)

1. Clonal analysis of hematopoietic stem cell development in vivo
2. Mechanisms of asymmetric cell division: two Bs or not two Bs, that is the question
3. Single cell origin of multilineage colonies in culture: evidence that differentiation of multipotent progenitors and restriction of proliferative potential of monopotent progenitors are stochastic processes
4. Disparate differentiation in hemopoietic colonies derived from human paired progenitors
5. Lineage commitment in human hemopoiesis involves asymmetric cell division of multipotent progenitors and does not appear to be influenced by cytokines
6. Hemopoietic spleen colony‐stimulating factors
7. The role of growth factors in self‐renewal and differentiation of hemopoietic stem cells
8. Lineage commitment of hemopoietic progenitor cells in developing blast cell colonies: influence of colony‐stimulating factors
9. A stochastic model of stem cell proliferation based on the growth of spleen colony forming cells
10. A stochastic model of stem cell proliferation based on the growth of spleen colony forming cells
11. Stochastic effects in hemopoiesis
12. Suppression of apoptosis allows differentiation and development of a multipotent hemopoietic cell line in the absence of added growth factors
13. Expression of the GM‐CSF gene after retroviral transfer in hematopoietic stem cell lines induces synchronous granulocyte‐macrophage differentiation
14. The erythroid‐specific transcription factor eryfl: a new finger protein
15. Cloning of cDNA for the major DNA‐binding protein of the erythroid lineage through expression in mammalian cells
16. Three new types of viral oncogenes of cellular origin specific for hematopoietic cell transformation
17. Myb: a transcriptional activator linking proliferation and differentiation in hematopoietic cells
18. Myb and NF‐M: combinatorial activators of myeloid genes in heterologous cell types
19. Homeobox genes in hematopoiesis
20. Homeobox genes and axial patterning
21. Organization of human class I homeobox genes
22. GATA‐binding factors in hematopoietic cells
23. Establishment in culture of pluripotential cells from mouse embryos
24. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells
25. Formation of germ‐line chimeras from embryo‐derived teratocarcinoma cell line
26. Erythroid differentiation in chimeric mice blocked by a targeted mutation in the gene for transcription factor GATA‐1
27. RAG‐2‐deficient blastocyst complementation: an assay of gene function in lymphocyte development
28. RAG‐2‐deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement
29. The in vitro development of blastocyst‐derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium
30. Early fetal hematopoietic development from in vitro differentiated embryonic stem cells
31. Hematopoietic development of embryonic stem cells in vitro: cytokine and receptor gene expression
32. Multiple hematopoietic lineages develop from embryonic stem (ES) cells in culture
33. Hematopoietic commitment during embryonic stem cell differentiation in culture
34. Establishment and characterization of lymphoid and myeloid mixed‐cell populations from mouse late embryoid bodies, “embryonic‐stem‐cell fetuses.”
35. In vitro differentiation of embryonic stem cells into lymphocyte precursors able to generate T and B lymphocytes in vivo
36. Lineage marker‐negative lymphocyte precursors derived from embryonic stem cells in vitro differentiate into mature lymphocytes in vivo
37. Inhibition of hematopoietic development from embryonic stem cells by antisense vav RNA
38. The macrophage and B cell‐specific transcription factor PU.1 is related to the ets oncogene
39. Erythroid regulatory elements
40. Cooperation of GATA‐1 and Sp1 can result in synergistic transcriptional activation or interference
41. Megakaryocytic and erythrocytic lineages share specific transcription factors
42. Transcriptional regulation of the rat platelet factor 4 gene: interaction between an enhancer‐silencer domain and the GATA site
43. GATA and Ets cis‐acting sequences mediate megakaryocyte‐specific expression
44. GATA‐binding transcription factors in mast cells regulate the promoter of the mast cell carboxypeptidase A gene
45. Dynamics of GATA transcription factor expression during erythroid differentiation
46. Cycle‐dependent initiation and lineage‐dependent abrogation of GATA‐1 expression in pure differentiating hematopoietic progenitors
47. Activation of the erythropoietin receptor promoter by transcription factor GATA‐1
48. Erythropoietin triggers a burst of GATA‐1 in normal human erythroid cells differentiating in tissue culture
49. GATA‐1 transactivates erythropoietin receptor gene, and erythropoietin receptor‐mediated signals enhance GATA‐1 gene expression
50. Novel insights into erythroid development revealed through in vitro differentiation of GATA‐1 embryonic stem cells
51. Rescue of erythroid development in gene targeted GATA‐1‐mouse embryonic stem cells
52. Functional analysis and in vivo footprinting implicate the erythroid transcription factor GATA‐1 as a positive regulator of its own promoter
53. Structure and promoter activity of the gene for the erythroid transcription factor GATA‐1
54. Expression of ets family genes in hematopoietic cells
55. Transactivation of GATA‐1 promoter with ETS1, ETS2 and ERGB/Hu‐FLI‐1 proteins: stabilization of the ETS1 protein binding on GATA‐1 promoter sequences by monoclonal antibody
56. An erythroid‐specific, developmental stage‐dependent enhancer far upstream of the human “β‐like globin” genes
57. Human globin locus activation region LAR: role in temporal control
58. A deletion of the human β‐globin locus activation region causes a major alteration in chromatin structure and replication across the entire β‐globin locus
59. Erythroid transcription factor NF‐E2 is a haematopoietic‐specific basic‐leucine zipper protein
60. The ubiquitous subunit of erythroid transcription factor NF‐E2 is a small basic‐leucine zipper protein related to the v‐maf oncogene
61. Inducibility of the HS II enhancer depends on binding of an erythroid specific nuclear protein
62. Detailed analysis of the site 3 region of the human beta‐globin dominant control regions
63. Two tissue‐specific factors bind the erythroid promoter of the human porphobilinogen deaminase gene
64. Expression of an erythroid transcription factor in megakaryocytic and mast cell lineages
65. SCL and related hemopoietic helix‐loop‐helix transcription factors
66. The SCL‐TAL‐1 gene is expressed in progenitors of both the hematopoietic and vascular systems during embryogenesis
67. Expression of tal‐1 and GATA‐binding proteins during human hematopoiesis
68. Structure of the gene encoding the murine SCL protein
69. A functional c‐myb gene is required for normal murine fetal hepatic hematopoiesis
70. C‐myb and growth control
71. Regulation of the expression of the hematopoietic stem cell antigen CD34: role of c‐myb
72. The oncogenic cysteine‐rich LIM domain protein rbtn2 is essential for erythroid development
73. The LIM motif defines a specific zinc‐binding protein domain
74. The LIM protein RBTN2 and the basic helix‐loop‐helix protein TAL1 present in a complex in erythroid‐cells
75. Generation and regeneration of cells of the B‐lymphocyte lineage
76. The regulated expression of B lineage associated genes during B cell differentiation in bone marrow and fetal liver
77. Human B lymphocytes: phenotpype, proliferation, and differentiation
78. An inhibitory carboxyl‐terminal domain in Ets‐1 and Ets‐2 mediates differential binding of ETS family factors to promoter sequences of the mb‐1 gene
79. A novel lineage‐specific nuclear factor regulates mb‐1 gene transcription at the early stages of B cell differentiation
80. BLyF, a novel cell‐type‐ and stage‐specific regulator of the B‐lymphocyte gene mb‐1
81. Cloning and functional characterization of early B‐cell factor, a regulator of lymphocyte‐specific gene expression
82. A pre‐B‐ and B cell‐specific DNA‐binding protein, EBB‐1, which binds to the promoter of the VpreB1 gene
83. A novel B‐cell lineage‐specific transcription factor present at early but not late stages of differentiation
84. Pax‐5 encodes the transcription factor BSAP and is expressed in B lymphocytes, the developing CNS, and adult testis
85. Pax‐5 is expressed at the mid‐brain‐hindbrain boundary during mouse development
86. The promoter of the CD19 gene is a target for the B‐cell‐specific transcription factor BSAP
87. Regulation of gene expression at early stages of B‐cell differentiation
88. The Ets family of transcription factors
89. Interaction of murine Ets‐1 with GGA‐binding sites establishes the ETS domain as a new DNA‐binding motif
90. Regulation of lymphoid‐specific immunoglobulin μ heavy chain gene enhancer by ETS‐domain proteins
91. PU.1 recruits a second nuclear factor to a site important for immunoglobulin κ 3′ enhancer activity
92. LyF‐1, a transcriptional regulator that interacts with a novel class of promoters for lymphocyte‐specific genes
93. Both LyF‐1 and an Ets protein interact with a critical promoter element in the murine terminal transferase gene
94. Ikaros, an early lymphoid‐specific transcription factor and a putative mediator for T cell commitment
95. Immunoglobulin gene transcription
96. Oct‐2, although not required for early B‐cell development, is critical for later B‐cell maturation and for postnatal survival
97. Targeted disruption of the Oct‐2 locus in a B cell provides genetic evidence for two distinct cell type‐specific pathways of octamer element‐mediated gene activation
98. A novel B cell‐derived coactivator potentiates the activation of immunoglobulin promoters by octamer‐binding transcription factors
99. LH‐2: a LIM/homeodomain gene expressed in developing lymphocytes and neural cells
100. Hex: a novel homeobox gene expressed during hematopoiesis and conserved between mouse and human
101. Novel murine homeobox gene on chromosome 1 expressed in specific hematopoietic lineages and during embryogenesis
102. Cloning of a human homeobox gene that resembles a diverged Drosophila homeobox gene and is expressed in activated lymphocytes
103. A diverged homeobox gene is involved in the proliferation and lineage commitment of human hematopoietic progenitors and highly expressed in acute myelogenous leukemia
104. A new DNA binding and dimerization motif in Ig enhancer binding, daughterless, MyoD, and Myc proteins
105. Two distinct transcription factors that bind the Ig enhancer μE5/κE2 motif
106. Helix‐loop‐helix proteins in the regulation of Ig gene transcription
107. E2A and E2‐2 are subunits of B‐cell‐specific E2‐box DNA‐binding proteins
108. E2A expression. Nuclear localization, and in vivo formation of DNA‐and non‐DNA‐binding species during B‐cell development
109. Kinetics of E2A basic helix‐loop‐helix expression during myelopoiesis and primary B cell differentiation
110. The protein Id: a negative regulator of helix‐loop‐helix DNA‐binding proteins
111. Repression of immunoglobulin enhancers by the helix‐loop‐helix protein Id: implications for B‐lymphoid‐cell development
112. Regulation of the NF‐κB/Rel transcription factor and IκB inhibitor system
113. Qualitative changes in the subunit composition of κB‐binding complexes during murine B‐cell differentiation
114. The v‐abl tyrosine kinase negatively regulates NF‐κB/Rel factors and blocks κ gene transcription in pre‐B lymphocytes
115. HMG domain proteins: architectural elements in the assembly of nucleoprotein structures
116. LEF‐1, a gene encoding a lymphoid‐specific protein, an HMG domain, regulates T‐cell receptor α enhancer function
117. Sox‐4, an Sry‐like HMG box protein, is a transcriptional activator in lymphocytes
118. A developmental pathway involving four phenotypically and functionally distinct subsets of CD3‐CD4‐CD8‐ triple‐negative adult mouse thymocytes defined by CD44 and CD25 expression
119. Gene transcription in differentiating immature T cell receptor neg thymocytes resembles antigen‐activated mature T cells
120. NF‐ATp: a transcription factor required for the co‐ordinate induction of several cytokine genes
121. Nuclear factor of activated T cells contains Fos and Jun
122. Characterization of the nuclear and cytoplasmic components of the lymphoid‐specific nuclear factor of activated T cells (NF‐AT) complex
123. Isolation of the cyclosporin‐sensitive T cell transcription factor NFATp
124. Analysis of the preexisting and nuclear forms of nuclear factor of activated T cells
125. NF‐AT components define a family of transcription factors targeted in T‐cell activation
126. Comparative analysis of NFAT (nuclear factor of activated T cells) complex in human T and B lymphocytes
127. Transcriptional regulation of T cell receptor genes
128. Functional GATA‐3 binding sites within murine CD8 alpha upstream regulatory sequences
129. HMG box proteins in early T‐cell differentiation
130. Identification and cloning of TCF‐1, a T lymphocyte‐specific transcription factor containing a sequence‐specific HMG Box
131. A thymus‐specific member of the HMG protein family regulates the human T cell receptor Cα enhancer
132. cis‐acting sequences required for inducible interleukin‐2 enhancer function bind a novel Ets‐related protein, Elf‐1
133. Characterization of the human CD4 gene promoter: transcription from the CD4 gene core promoter is tissue‐specific and is activated by Ets proteins
134. Characterization of the human interleukin‐2 receptor beta‐chain gene promoter: regulation of promoter activity by ets gene products
135. Transcriptional regulation of T‐cell genes during T‐cell development
136. Cooperative binding of Ets‐1 and core binding factor to DNA
137. Differential protein binding in lymphocytes to a sequence in the enhancer of the mouse retrovirus SL3‐3
138. Identification of the SL3‐3 virus enhancer core as a T lymphoma cell‐specific element
139. Differential expression of a subspecies of polyomavirus and murine leukemia virus enhancer core binding protein, PEBP2, in various hematopoietic cells
140. Binding of SL3‐3 enhancer factor 1 transcriptional activators to viral and chromosomal enhancer sequences
141. Purification of core‐binding factor, a protein that binds the conserved core site in murine leukemia virus enhancers
142. Cloning and characterization of subunits of the T‐cell receptor and murine leukemia virus enhancer core‐binding factor
143. T(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1
144. The T(8;21) translocation in acute myeloid leukemia results in production of an AML1‐MTG8 fusion transcript
145. The runt domain identifies a new family of heteromeric transcriptional regulators (letter)
146. A novel POU domain protein which binds to the T‐cell receptor β enhancer
147. Identification of homeobox genes expressed in human T‐lymphocytes
148. Expression of HOX C homeobox genes in lymphoid cells
149. Expression and regulation of myeloid‐specific genes in normal and leukemic myeloid cells
150. Colony‐stimulating factor‐1 receptor
151. The macrophage transcription factor PU.1 directs tissue‐specific expression of the macrophage colony‐stimulating factor receptor
152. The protooncogene PU.1 regulates expression of the myeloid‐specific CD11b promoter
153. Hematopoietic lineage‐ and stage‐restricted expression of the ETS oncogene family member PU.1
154. Comparison of the expression and function of the transcription factor PU.1 (SPI‐1 proto‐oncogene) between murine macrophages and B lymphocytes
155. Ets‐related protein PU.1 regulates expression of the immunoglobulin J‐chain gene through a novel Ets‐binding element
156. Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages
157. The murine myeloperoxidase promoter contains several functional elements, one of which binds a cell type‐restricted transcription factor, myeloid nuclear factor 1 (MyNF1)
158. A retinoic acid‐responsive human zinc finger gene. MZF1, preferentially expressed in myeloid cells
159. Characterization of the DNA‐binding properties of the myeloid zinc finger protein MZF1: two independent DNA‐binding domains recognize two DNA consensus sequences with a common G‐rich core
160. Antisense oligonucleotides from the stage‐specific myeloid zinc finger gene MZF1 inhibit granulopoiesis in vitro
161. The v‐myb oncogene product binds to and activates the promyelocyte‐specific mim‐1 gene
162. Identification of a rat liver nuclear protein that binds the enhancer core element of three animal viruses
163. Isolation of a recombinant copy of the gene encoding C/EBP
164. A novel temporal expression pattern of three C/EBP family members in differentiating myelomonocytic cells
165. A human Hox 1 homeobox gene exhibits myeloid‐specific expression of alternative transcripts in human hematopoietic cells
166. CCAAT displacement protein as a repressor of the myelomonocytic‐specific gp91‐phox gene promoter
167. Human CCAAT displacement protein is homologous to the Drosophila homeoprotein, cut
168. Acute promyelocytic leukemia: from genetics to treatment
169. A dominant negative retinoic acid receptor blocks neutrophil differentiation at the promyelocyte stage